Needham & Company Downgrades Theseus Pharmaceuticals Inc. (THRX) to Hold
Tweet
Share
E-mailGet Alerts THRX Hot Sheet
Price: $4.06 --0%
Rating Summary:
6 Buy, 5 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 5 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Needham & Company analyst Ami Fadia downgraded Theseus Pharmaceuticals Inc. (NASDAQ: THRX) from Buy to Hold.
For an analyst ratings summary and ratings history on Theseus Pharmaceuticals Inc. click here. For more ratings news on Theseus Pharmaceuticals Inc. click here.
Shares of Theseus Pharmaceuticals Inc. closed at $9.52 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- HSBC Downgrades Cisco (CSCO) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
